Equities
US stocks rise on Fed rate pause hopes; Swiss franc strengthens
Wall Street advances as investors bet on a September Fed pause, while the Swiss franc gains after higher-than-expected Swiss inflation. SMI mixed as Nestlé weighs on index.
Zumtobel Q1 FY2026/27 margins rise on cost cuts despite flat revenue
Austrian lighting group Zumtobel posted a 25% rise in adjusted EBIT to €8.2 million in Q1 FY2026/27, even as revenue slipped 0.9% to €264.1 million. Guidance maintained for flat annual sales.
Swiss stocks rise on US gains; Nestlé, Richemont drag; franc strengthens
Swiss Market Index edges up 0.2% after early 0.5% gain as Nestlé drags; Roche and Logitech lead gains. Euro falls to 0.9384 francs as Swiss inflation surprises.
US stocks rise on softer yields; Swiss franc strengthens after inflation surprise
U.S. benchmarks advance 0.4-0.6% at open as Treasury yields ease; SMI up 0.5% led by Roche and Logitech. Swiss inflation hits two-year high, lifting franc to 0.9392 per euro.
UBS identifies four European investment themes as earnings rebound gains traction
Strategists flag industrials, banks, quality leaders and Swiss mid-caps as Europe’s earnings cycle shifts from stagnation to growth, with 15% EPS growth forecast for 2026.
US stocks set for modest gain; SMI rises on Roche, Logitech gains; Swiss franc strengthens
U.S. futures point to a modestly higher open as Middle East tensions ease slightly. Swiss Market Index climbs 0.2% on Roche and Logitech gains, while the franc strengthens after Swiss inflation surprises.
US stocks cautious as oil prices rise; Swiss franc strengthens on inflation data
Dow Jones and Nasdaq futures show muted gains ahead of key U.S. jobs data, while rising oil prices and geopolitical tensions curb risk appetite. Swiss franc surges to 0.9392 per euro after unexpected inflation jump.
Swiss stocks steady as SMI faces direction; Nestlé weighs, Swatch falls; franc strengthens
Swiss market opens flat with Nestlé down 0.67% while Swatch drops 2.3%; franc gains to 0.9392 per euro and 0.8092 per dollar after August inflation hits 0.8%.
Aebi Schmidt raises 2030 revenue target to CHF 3 bln on M&A, synergies
Swiss industrial group lifts long-term revenue and EBITDA margin goals after Shyft acquisition, targeting 50% organic growth and 50% from deals. Management cites margin expansion from U.S. footprint and after-sales expansion.
Frankfurt stocks rise as Nvidia, US tech earnings lift DAX 0.31%
German equities advanced Thursday as strong U.S. tech earnings offset uncertainty ahead of the Jackson Hole central bank symposium. Nvidia's AI chip outlook drove gains in tech-heavy sectors.
Swiss Market Index falls 1.1% as heavyweights weigh on SMI
Partners Group gains 2.2%, Gurit surges 14% while Nestlé, Novartis and Roche decline. US tech rally lifts Nasdaq 100 to 29,518 as Nvidia, Salesforce and CrowdStrike advance.
Jefferies upgrades EU utilities with RWE, E.ON, EDP as power prices rise
Brokerage names RWE as top power pick, E.ON as top regulated utility, and EDP as top integrated utility amid surging European power prices and regulatory tailwinds.
US stocks fluctuate as tech gains offset losses; SMI pares declines
Dow futures edge higher while Nasdaq 100 slips; energy price surge fuels inflation concerns ahead of Fed decision. Swiss market pares losses with defensive stocks leading gains.
DAX extends losses as oil prices and bond yields rise
German blue-chip index falls 0.44% to 25,856 amid elevated oil prices and bond yields, while MDax declines 1.04%. Geopolitical tensions in the Middle East further support crude prices.
Morgan Stanley lifts ratings on Coloplast, Demant in European MedTech
Analysts raise targets on hearing-aid names and rebalance coverage after strategic updates, while downgrading Smith & Nephew to equal weight. Sector remains in-line.
DAX inclusion shows mixed long-term stock performance gains
Deutsche Bank analysis finds new DAX entrants underperform the index by a median 8% in their first year, despite short-term liquidity boosts. Changes effective September 21.
Swiss stocks slip as oil, rate fears weigh on markets
SMI falls 0.4% as Brent crude tops $95, inflation and ECB/Fed policy expectations drive defensive rotation; Roche, Swiss Life gain while Amrize, Holcim lag.
Nvidia lifts US tech as Salesforce jumps; SMI hits session low
Nvidia surged 8% premarket after strong outlook, lifting the Nasdaq 100, while Salesforce rallied 10% on AI-driven growth guidance. Swiss equities fell 1.2% as heavyweights weighed.
Swiss equities slip as oil, inflation and rate fears weigh
SMI falls 0.4% to 14,280 as defensive shares lag; Amrize drops 2.7% after BofA downgrade, Roche and Swiss Life advance. Brent crude tops $95/bbl after U.S.-Iran strikes.
US stocks slip at week open as oil spikes, geopolitics weigh
Dow Jones falls 0.4% as Brent crude tops $91; Aon shares drop on $17bn KKR deal; GameStop warns on Q2 revenue amid store closures.
Swiss stocks fall as oil surge fuels inflation concerns; UBS upgrades Comet, VAT, Inficon
SMI drops 0.1% as Brent crude tops $95 a barrel after U.S.-Iran tensions escalate; UBS lifts targets on Swiss tech names. Nestlé to sell vitamins unit for $1 billion.
Nvidia’s strong results lift Swiss chip suppliers modestly amid mixed market signals
Comet, Inficon and VAT Group gain 1.4%-2.1% after Nvidia’s Q2 revenue surge, but broader semiconductor volatility remains subdued. Analysts cite solid fundamentals for VAT as Citigroup sets a 850-franc target.
US tech shares rise on Nvidia rally; Swiss SMI falls on heavyweights
Nasdaq 100 gains 1% as Nvidia soars 7.3% on AI demand; S&P 500 up 0.46%; HP drops 6% on weak outlook; Swiss SMI down 1.2% as heavyweights weigh.
Novartis shares hit record high on multiple sclerosis drug data
Swiss pharma giant rallies 6.3% after positive late-stage trial results for oral multiple sclerosis drug Remibrutinib, outpacing broader market slump. Analysts flag upside potential but warn of near-term consolidation risks.